Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Proshares Trust (ZBIO) Gains from Sales and Divestitures (2024)

Historic Gains from Sales and Divestitures for Zenas BioPharma (ZBIO) over the last 1 years, with Q4 2024 value amounting to $6028.0.

  • Zenas BioPharma's Gains from Sales and Divestitures changed N/A to $6028.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $6028.0, marking a year-over-year change of. This contributed to the annual value of $6028.0 for FY2024, which is N/A changed from last year.
  • Zenas BioPharma's Gains from Sales and Divestitures amounted to $6028.0 in Q4 2024.
  • In the past 5 years, Zenas BioPharma's Gains from Sales and Divestitures ranged from a high of $6028.0 in Q4 2024 and a low of $6027.0 during Q3 2024